2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4365):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W066651
    1-tert-Butyl 3-methyl 3-hydroxyazetidine-1,3-dicarboxylate
    1-tert-Butyl 3-methyl 3-hydroxyazetidine-1,3-dicarboxylate is a drug intermediate for synthesis of various active compounds.
    1-tert-Butyl 3-methyl 3-hydroxyazetidine-1,3-dicarboxylate
  • HY-Z0059
    Sacubitrilat impurity 32
    		99.96%
    Sacubitrilat impurity 32 is an impurity of Sacubitrilat (HY-17620).
    Sacubitrilat impurity 32
  • HY-W016618
    Ethyl phenylglyoxylate
    		99.51%
    Ethyl phenylglyoxylate (Ethyl benzoylformate), the ethyl ester of phenylglyoxylic acid, is used as a synthetic reagent. Ethyl phenylglyoxylate is also a poor substrate but a potent inhibitor of chicken liver carboxylesterase. Additionally, Ethyl phenylglyoxylate exhibits photoreactivity, where its excited triplet carbonyl can initiate intermolecular hydrogen abstraction, radical coupling and cross-linking reactions.
    Ethyl phenylglyoxylate
  • HY-W044751
    (R)-Octahydro-pyrido[1,2-A]pyrazine
    		98.0%
    (R)-Octahydro-pyrido[1,2-A]pyrazine is a drug intermediate for synthesis of various active compounds.
    (R)-Octahydro-pyrido[1,2-A]pyrazine
  • HY-131546
    Levofloxacin Q-acid
    		99.79%
    Levofloxacin Q-acid (Levofloxacin carboxylic acid) is an intermediate in the synthesis of the antibiotic Levofloxacin (HY-B0330).
    Levofloxacin Q-acid
  • HY-W086093
    tert-Butyl 2-{3-[3-(3,4-dimethoxyphenyl)propanoyl]phenoxy}acetate
    		99.72%
    tert-Butyl 2-{3-[3-(3,4-dimethoxyphenyl)propanoyl]phenoxy}acetate is a drug intermediate for synthesis of various active compounds.
    tert-Butyl 2-{3-[3-(3,4-dimethoxyphenyl)propanoyl]phenoxy}acetate
  • HY-W015947
    1,2-Dimethylimidazole
    		99.99%
    1,2-Dimethylimidazole is a pharmaceutical raw material and intermediate containing nitrogen-containing group.
    1,2-Dimethylimidazole
  • HY-79058
    7,8-Dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione
    		99.01%
    7,8-Dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione (5H-Cyclohepta[b]pyridine-7,8-dihydro-5,9(6H)-dione) is a drug intermediate for synthesis of various active compounds.
    7,8-Dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione
  • HY-W012617
    Nicotinohydrazide
    		99.35%
    Nicotinohydrazide (Nicotinic acid hydrazide) is a precursor used for synthesizing hydrazone derivatives with antibacterial and antifungal activities. Nicotinohydrazide can be used in studies of bacterial and fungal infections.
    Nicotinohydrazide
  • HY-43859
    4-(2,4-Difluorophenoxy)benzoic acid
    		98.95%
    4-(2,4-Difluorophenoxy)benzoic acid is a drug intermediate for synthesis of various active compounds.
    4-(2,4-Difluorophenoxy)benzoic acid
  • HY-30809
    2-Benzyl-2,5-diazaspiro[3.4]octane dihydrochloride
    		99.02%
    2-Benzyl-2,5-diazaspiro[3.4]octane dihydrochloride is a drug intermediate for synthesis of various active compounds.
    2-Benzyl-2,5-diazaspiro[3.4]octane dihydrochloride
  • HY-W097093
    Ropinirole impurity 12
    Ropinirole impurity 12 is an impurity of Ropinirole.
    Ropinirole impurity 12
  • HY-W038588
    2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-2-en-1-one
    2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-2-en-1-one is a drug intermediate for synthesis of various active compounds.
    2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-2-en-1-one
  • HY-76805
    (2-Phenylquinolin-7-yl)methanol
    		98.82%
    (2-Phenylquinolin-7-yl)methanol is a drug intermediate for synthesis of various active compounds.
    (2-Phenylquinolin-7-yl)methanol
  • HY-76645
    tert-Butyl((1S,5R,6S)-3-azabicyclo[3.3.0]octan-6-yl)carbamate
    tert-Butyl((1S,5R,6S)-3-azabicyclo[3.3.0]octan-6-yl)carbamate is a drug intermediate for synthesis of various active compounds.
    tert-Butyl((1S,5R,6S)-3-azabicyclo[3.3.0]octan-6-yl)carbamate
  • HY-W040471
    3′,5′-Dimethoxyacetophenone
    		99.91%
    3′,5′-Dimethoxyacetophenone is a ketone compound with antioxidant activity. 3′,5′-Dimethoxyacetophenone is also a building block in chemical synthesis.
    3′,5′-Dimethoxyacetophenone
  • HY-N8275
    (R)-(+)-Citronellic acid
    		99.45%
    (R)-(+)-Citronellic acid is a chiral carboxylic acid and can be used as a drug intermediate.
    (R)-(+)-Citronellic acid
  • HY-I0148
    N-[5-(Methoxycarbonyloxy)-2,4-di(tert-butyl)phenyl]-4-oxo-1H-quinoline-3-carboxamide
    		98.05%
    N-[5-(Methoxycarbonyloxy)-2,4-di(tert-butyl)phenyl]-4-oxo-1H-quinoline-3-carboxamide (Ivacaftor Methylcarbonate) is a drug intermediate for synthesis of various active compounds.
    N-[5-(Methoxycarbonyloxy)-2,4-di(tert-butyl)phenyl]-4-oxo-1H-quinoline-3-carboxamide
  • HY-42418
    3-Methyl-N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-valyl-(4R)-4-hydroxy-L-proline
    		99.07%
    3-Methyl-N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-valyl-(4R)-4-hydroxy-L-proline is a drug intermediate for synthesis of various active compounds.
    3-Methyl-N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-valyl-(4R)-4-hydroxy-L-proline
  • HY-160916
    N3-PEG8-Oxydiacetamide-Phe-Lys(MMT)-PAB-PNP
    N3-PEG8-Oxydiacetamide-Phe-Lys(MMT)-PAB-PNP (compound 18) is a pharmaceutical synthesis intermediate for the SN-38 (HY-13704) derivative.
    N3-PEG8-Oxydiacetamide-Phe-Lys(MMT)-PAB-PNP